{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:53:35Z","timestamp":1790675615193,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1475-2875-12-359","type":"journal-article","created":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T23:11:11Z","timestamp":1381360271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate"],"prefix":"10.1186","volume":"12","author":[{"given":"Holly","family":"Matthews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Usman-Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niroshini","family":"Nirmalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,9]]},"reference":[{"key":"2975_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0140-6736(04)16680-4","volume":"364","author":"PG Kremsner","year":"2004","unstructured":"Kremsner PG, Krishna S: Antimalarial combinations. Lancet. 2004, 364: 285-294. 10.1016\/S0140-6736(04)16680-4.","journal-title":"Lancet"},{"key":"2975_CR2","volume-title":"Global report on antimalarial drug efficacy and drug resistance: 2000\u20132010","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Global report on antimalarial drug efficacy and drug resistance: 2000\u20132010. 2010, Geneva: WHO"},{"key":"2975_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrmicro2385","volume":"8","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, Socheat D, Von Seidlein L: Artemisinin resistance: current status and scenarios for containment. Nat Rev Micro. 2010, 8: 272-280.","journal-title":"Nat Rev Micro"},{"key":"2975_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pt.2010.09.004","volume":"27","author":"R Jambou","year":"2011","unstructured":"Jambou R, Le Bras J, Randrianarivelojosia M: Pitfalls in new artemisinin-containing antimalarial drug development. Trends Parasitol. 2011, 27: 82-90. 10.1016\/j.pt.2010.09.004.","journal-title":"Trends Parasitol"},{"key":"2975_CR5","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1016\/j.bmcl.2007.04.054","volume":"17","author":"JJ Walsh","year":"2007","unstructured":"Walsh JJ, Coughlan D, Heneghan N, Gaynor C, Bell A: A novel artemisinin-quinine hybrid with potent antimalarial activity. Bioorg Med Chem Lett. 2007, 17: 3599-3602. 10.1016\/j.bmcl.2007.04.054.","journal-title":"Bioorg Med Chem Lett"},{"key":"2975_CR6","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"NJ White","year":"2004","unstructured":"White NJ: Antimalarial drug resistance. J Clin Invest. 2004, 113: 1084-1092.","journal-title":"J Clin Invest"},{"key":"2975_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB: Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004, 3: 673-683. 10.1038\/nrd1468.","journal-title":"Nat Rev Drug Discov"},{"key":"2975_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.drudis.2011.02.016","volume":"16","author":"S Ekins","year":"2011","unstructured":"Ekins S, Williams AJ, Krasowski MD, Freundlich JS: In silico repositioning of approved drugs for rare and neglected diseases. Drug Discov Today. 2011, 16: 298-310. 10.1016\/j.drudis.2011.02.016.","journal-title":"Drug Discov Today"},{"key":"2975_CR9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.47276\/lr.78.3.197","volume":"78","author":"SL Walker","year":"2007","unstructured":"Walker SL, Waters MF, Lockwood DN: The role of thalidomide in the management of erythema nodosum leprosum. Lepr Rev. 2007, 78: 197-215.","journal-title":"Lepr Rev"},{"key":"2975_CR10","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/archinte.162.12.1349","volume":"162","author":"HA Fink","year":"2002","unstructured":"Fink HA, Mac Donald R, Rutks IR, Nelson DB, Wilt TJ: Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2002, 162: 1349-1360. 10.1001\/archinte.162.12.1349.","journal-title":"Arch Intern Med"},{"key":"2975_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0167-6296(91)90001-4","volume":"10","author":"JA DiMasa","year":"1991","unstructured":"DiMasa JA, Hansen RW, Grabowski HG, Lasagna L: Cost of innovation in the pharmaceutical industry. J Health Econ. 1991, 10: 107-142. 10.1016\/0167-6296(91)90001-4.","journal-title":"J Health Econ"},{"key":"2975_CR12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1517\/13543784.15.11.1295","volume":"15","author":"LA Tartaglia","year":"2006","unstructured":"Tartaglia LA: Complementary new approaches enable repositioning of failed drug candidates. Expert Opin on Investig Drugs. 2006, 15: 1295-1298. 10.1517\/13543784.15.11.1295.","journal-title":"Expert Opin on Investig Drugs"},{"key":"2975_CR13","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.4155\/fmc.11.95","volume":"3","author":"A Nzila","year":"2011","unstructured":"Nzila A, Ma Z, Chibale K: Drug repositioning in the treatment of malaria and TB. Future Med Chem. 2011, 3: 1413-1426. 10.4155\/fmc.11.95.","journal-title":"Future Med Chem"},{"key":"2975_CR14","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.4155\/fmc.11.91","volume":"3","author":"JN Burrows","year":"2011","unstructured":"Burrows JN, Leroy D, Lotharius J, Waterson D: Challenges in antimalarial drug discovery. Future Med Chem. 2011, 3: 1401-1412. 10.4155\/fmc.11.91.","journal-title":"Future Med Chem"},{"key":"2975_CR15","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1128\/AAC.00431-10","volume":"54","author":"E Lucumi","year":"2010","unstructured":"Lucumi E, Darling C, Jo H, Napper AD, Chandramohandas R, Fisher N, Shone AE, Jing H, Ward SA, Biagini GA, DeGrado WF, Diamond SL, Greenbaum DC: Discovery of potent small molecule inhibitors of multi drug-resistant Plasmodium falciparum using a novel miniaturised high throughput luciferase-based assay. Antimicrob Agents Chemother. 2010, 54: 3579-3604.","journal-title":"Antimicrob Agents Chemother"},{"key":"2975_CR16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(02)08348-4","volume":"359","author":"M Adjuik","year":"2002","unstructured":"Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WR: Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised multicentre trial. Lancet. 2002, 359: 1365-1372. 10.1016\/S0140-6736(02)08348-4.","journal-title":"Lancet"},{"key":"2975_CR17","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/S0140-6736(05)66417-3","volume":"365","author":"TK Mutabingwa","year":"2005","unstructured":"Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ: Amodiaquine alone, amodiaquine\u2009+\u2009sulfodoxine-pyremethamin, amodiaquine\u2009+\u2009artesunate and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four armed randomised effectiveness trial. Lancet. 2005, 365: 1474-1480. 10.1016\/S0140-6736(05)66417-3.","journal-title":"Lancet"},{"key":"2975_CR18","volume-title":"Antimalarial drug combination therapy (WHO\/CDS\/RBM\/2001.35)","author":"World Health Organization","year":"2001","unstructured":"World Health Organization: Antimalarial drug combination therapy (WHO\/CDS\/RBM\/2001.35). 2001, Geneva: WHO"},{"key":"2975_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1385\/0-89603-239-6:43","volume-title":"Protocols in Molecular Parasitology. (Hyde JE Ed.). Volume 21","author":"M Read","year":"1993","unstructured":"Read M, Hyde JE: Simple in vitro culture of the malaria parasite Plasmodium falciparum (erythrocytic stages): suitable for large-scale preparations. Protocols in Molecular Parasitology. (Hyde JE Ed.). Volume 21. 1993, 43-55."},{"key":"2975_CR20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB: Human malaria parasites in continuous culture. Science. 1976, 193: 673-675. 10.1126\/science.781840.","journal-title":"Science"},{"key":"2975_CR21","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1016\/j.ejmech.2009.02.008","volume":"44","author":"A Bhattacharya","year":"2009","unstructured":"Bhattacharya A, Mishra LC, Sharma M, Awasthi SK, Bhasin VK: Antimalarial pharmacodynamics of chalcone derivatives in combination with artemisninin against Plasmodium falciparum in vitro. Eur J Med Chem. 2009, 44: 3388-3393. 10.1016\/j.ejmech.2009.02.008.","journal-title":"Eur J Med Chem"},{"key":"2975_CR22","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4269\/ajtmh.2010.09-0417","volume":"82","author":"MG Vossen","year":"2010","unstructured":"Vossen MG, Pferschy S, Chiba P, Noedl H: The SYBR Green I malaria drug sensitivity assay: performance in low parasitaemia samples. Am J Trop Med Hyg. 2010, 82: 398-401. 10.4269\/ajtmh.2010.09-0417.","journal-title":"Am J Trop Med Hyg"},{"key":"2975_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.trstmh.2008.01.021","volume":"102","author":"MA Rason","year":"2008","unstructured":"Rason MA, Randriantsoa T, Andrianantenaina H, Ratsimbasoa A, Menard D: Performance and reliability of the SYBR Green 1 based assay for the routine monitoring of susceptibility of Plasmodium falciparum in clinical isolates. Trans R Soc Trop Med Hyg. 2008, 102: 346-351. 10.1016\/j.trstmh.2008.01.021.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2975_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/1475-2875-8-294","volume":"8","author":"S Karl","year":"2009","unstructured":"Karl S, Wong RPM, St Pierre TG, Davis TME: A comparative study of a flow cytometry based assessment of in vitro Plasmodium falciparum drug sensitivity. Malar J. 2009, 8: 294-10.1186\/1475-2875-8-294.","journal-title":"Malar J"},{"issue":"1","key":"2975_CR25","first-page":"1","volume":"8","author":"R Lasserre","year":"1979","unstructured":"Lasserre R: Treatment of amoebiasis. Phil J Microbiol Infect Dis. 1979, 8 (1): 1-","journal-title":"Phil J Microbiol Infect Dis"},{"key":"2975_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1476-5381.1996.tb15202.x","volume":"117","author":"R Lemmens-Gruber","year":"1996","unstructured":"Lemmens-Gruber R, Karkhaneh A, Studenik C, Heistracher P: Cardiotoxicity of emetine dihydrochloride by calcium channel blockade in isolated preparations and ventricular myocytes of guinea-pig hearts. Brit J Pharmacol. 1996, 117: 377-383. 10.1111\/j.1476-5381.1996.tb15202.x.","journal-title":"Brit J Pharmacol"},{"key":"2975_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0163-7258(80)90007-8","volume":"10","author":"WC Yang","year":"1980","unstructured":"Yang WC, Dubick MW: Mechanism of Emetine toxicity. Pharmacol Ther. 1980, 10: 15-26. 10.1016\/0163-7258(80)90007-8.","journal-title":"Pharmacol Ther"},{"key":"2975_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/hrt.28.4.505","volume":"28","author":"JJ Dempsey","year":"1966","unstructured":"Dempsey JJ, Salem HH: An enzymatic electrocardiographic study on toxicity of dehydroemetine. Brit Heart J. 1966, 28: 505-511. 10.1136\/hrt.28.4.505.","journal-title":"Brit Heart J"},{"key":"2975_CR29","first-page":"591","volume":"17","author":"T Chintana","year":"1986","unstructured":"Chintana T, Sucharit P, Mahakittikun V, Siripanth C, Suphadtanaphongs W: In vitro studies on the sensitivity of local Entamoeba histolytica to anti-amoebic drugs. Southeast Asian J Trop Med Public Health. 1986, 17: 591-594.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2975_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1476-0711-3-27","volume":"3","author":"D Bansal","year":"2004","unstructured":"Bansal D, Sehgal R, Chawla Y, Mahajan RC, Malla N: In vitro activity of antiamoebic drugs against clinical isolates of Entamoeba histolytica and Entamoeba dispar. Ann Clin Microbiol Antimicrob. 2004, 3: 27-31. 10.1186\/1476-0711-3-27.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2975_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1475-2875-12-43","volume":"12","author":"OO Abiodun","year":"2013","unstructured":"Abiodun OO, Brun R, Sergio W: In vitro interaction of artemisinin derivatives or the fully synthetic peroxidic antimalarial OZ277 with thapsigargin in P. falciparum strains. Malar J. 2013, 12: 43-10.1186\/1475-2875-12-43.","journal-title":"Malar J"},{"key":"2975_CR32","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/jac\/dkl563","volume":"59","author":"L Vivas","year":"2007","unstructured":"Vivas L, Rattray L, Stewart LB, Robinson BL, Fugmann B, Haynes RK, Peters W, Croft SL: Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo. J Antimicrob Chemother. 2007, 59: 658-665. 10.1093\/jac\/dkl563.","journal-title":"J Antimicrob Chemother"},{"key":"2975_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1006\/expr.1995.1049","volume":"80","author":"CJ Canfield","year":"1995","unstructured":"Canfield CJ, Pudney M, Gutteridge WE: Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitol. 1995, 80: 373-381. 10.1006\/expr.1995.1049.","journal-title":"Exp Parasitol"},{"key":"2975_CR34","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","volume":"48","author":"QL Fivelman","year":"2004","unstructured":"Fivelman QL, Adagu IS, Warhurst DC: Modified fixed-ratio isbologram method for studying in vitro interactions between atovoquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob Agents Chemother. 2004, 48: 4097-4102. 10.1128\/AAC.48.11.4097-4102.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"2975_CR35","first-page":"183","volume-title":"Synergism and Antagonism in Chemotherapy","author":"JL Bennerstrom","year":"2001","unstructured":"Bennerstrom JL, Ellis WY, Milhouse WK, Eaton RM: Antimalarial synergism and antagonism. Synergism and Antagonism in Chemotherapy. Edited by: Chou TC, Rideout DC. 2001, New York: Academic Press, Inc, 183-222."},{"key":"2975_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.femsle.2005.09.035","volume":"253","author":"A Bell","year":"2005","unstructured":"Bell A: Antimalarial synergism and antagonism: mechanistic and clinical significance. FEMS Microbiol Lett. 2005, 253: 171-184. 10.1016\/j.femsle.2005.09.035.","journal-title":"FEMS Microbiol Lett"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-12-359.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:40:40Z","timestamp":1630546840000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-12-359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2975"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-12-359","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,9]]},"assertion":[{"value":"26 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"359"}}